Filing Flows › Nurix Therapeutics (NRIX) › How it makes money
How Nurix Therapeutics (NRIX) makes money
Nurix Therapeutics (NRIX) made $673M of revenue in the third quarter fiscal 2026 (Q3 FY26), up 85-fold from a year earlier. License revenue brought in $653M (97%); Collaboration revenue brought in $19.9M (3%). Of every dollar of revenue, 83¢ was left as operating profit, 82¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q3 FY26
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| License revenue | $653M | 97.0% | — | — |
| Collaboration revenue | $19.9M | 3.0% | — | +152% |
Where each dollar of revenue goes
| Line | Q3 FY26 | % of revenue |
|---|---|---|
| Revenue | $673M | 100.0% |
| Operating profit | $559M | 83.1% |
| Income tax | $13.6M | 2.0% |
| Net earnings | $550M | 81.7% |
| Operating cash flow | $616M | 91.5% |
| Free cash flow | $614M | 91.3% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 FY26 | $673M | 85× |
| Q2 FY26 | $9.0M | -80% |
| Q1 FY26 | $6.3M | -66% |
| Q4 FY25 | $13.6M | +2% |
| Q3 FY25 | $7.9M | -37% |
| Q2 FY25 | $44.1M | +264% |
| Q4 FY24 | $13.3M | -12% |
From Nurix Therapeutics' 10-Q filed Oct 13, 2026 (on EDGAR).
Questions
How does Nurix Therapeutics make money?
Nurix Therapeutics (NRIX) made $673M of revenue in the third quarter fiscal 2026 (Q3 FY26), up 85-fold from a year earlier. License revenue brought in $653M (97%); Collaboration revenue brought in $19.9M (3%). Of every dollar of revenue, 83¢ was left as operating profit, 82¢ was left as net earnings.
What is Nurix Therapeutics' biggest business?
License revenue: $653M in the third quarter fiscal 2026, 97% of revenue.
What is Nurix Therapeutics' profit margin?
Net earnings were $550M, 81.7% of revenue, in the third quarter fiscal 2026; the operating margin was 83.1%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.